§ Mr. Ashley
asked the Secretary of State for Social Services if he will monitor the number of prescriptions issued for products containing oxyphenbutazone from 6 March to the date when further action is taken on the licence for these products.
§ Mr. Kenneth Clarke
No. I see no justification for monitoring these products while a decision about their licensing is being considered under the Medicines Act.